Search Results

Gland Pharma jumps on getting USFDA's nod for Latanoprost Ophthalmic Solution.

Subjects: OCULAR hypertension; OPEN-angle glaucoma; INTRAOCULAR pressureUNITED States. Food & Drug Administration

• Source: Ace Analyser: Company News. 12/3/2024, pN.PAG-N.PAG. 1p.

Record details

Aerie Pharmaceuticals Shares Jump Most Ever on Eye Drug Results.

• Authors : Mittelman, Melissa (AUTHOR)

Subjects: DRUGS; OCULAR hypertension

• Source: Bloomberg.com. 9/17/2015, pN.PAG-N.PAG. 1p.

Record details

Preservative-free Therapy Launches to Reduce Intraocular Pressure in Glaucoma.

Subjects: *COST analysis; *PHARMACEUTICAL industry; GLAUCOMA

• Source: Formulary Watch. 9/26/2023, p1-2. 2p.

Record details

Cracked Lids Leads to Recall of Six Lots of Brimonidine Tartrate Solution.

Subjects: *PRODUCT recall; *DRUG packaging; GLAUCOMA

• Source: Formulary Watch. 3/3/2023, p1-2. 2p.

Record details

Dorzolamide nanoliposome as a long action ophthalmic delivery system in open angle glaucoma and ocular hypertension patients.

• Authors : Kouchak, Maryam^1,2 (AUTHOR); Malekahmadi, Mohammad³ (AUTHOR); Bavarsad, Neda^1,2 (AUTHOR)

Subjects: AMIDE derivatives; OPEN-angle glaucoma; LIPOSOMES

• Source: Drug Development & Industrial Pharmacy. Aug2018, Vol. 44 Issue 8, p1239-1242. 4p.

Record details

Study evaluates role of medicine in ocular hypertension.

• Authors : Kass, Michael A.; Parrish, Richard

Subjects: GLAUCOMA treatment; TREATMENT of eye diseases

• Source: Ophthalmology Times. 03/15/2001, Vol. 26 Issue 6, p8. 2p.

Record details

Glaukos Launches Implantable Glaucoma Treatment.

Subjects: GLAUCOMA treatment; PROSTHETICS; GLAUCOMAUNITED StatesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/29/2024, p1-1. 1p.

Record details

FDA Approves Omlonti for Glaucoma.

Subjects: *SOCIOECONOMIC factors; DRUG approval; GLAUCOMAUNITED States. Food & Drug Administration

• Source: Formulary Watch. 9/27/2022, p1-1. 1p.

Record details

CVS Caremark Removes 5 Brands from Drug List.

• Authors : Myshko, Denise

Subjects: *INSURANCE companies; *PHARMACEUTICAL services insurance; ZOLMITRIPTAN

• Source: Formulary Watch. 2/15/2023, p1-1. 1p.

Record details

Dorzolamide and Timolol Ophthalmic.

• Source: ASHP Patient Medication Information - English Version. Mar2022, p1-1. 1p.

Record details